Career Enhancement Program

摘要：职业提升计划(CEP)。爱荷华大学/梅奥诊所的目标 淋巴瘤孢子(孢子)职业提升计划(CEP)是提供支持(包括经济支持 支持和广泛的指导)给非常有前途、训练有素的科学家，有兴趣在 转化性淋巴瘤研究。CEP允许每年支持两个非常有希望的 从事孢子研究的调查人员。广泛的研究和培训基地，可在 这两个机构以及孢子的基础设施为 孢子CEP.孢子CEP的成功候选人通常是年轻的研究人员(高级博士后 即将开始其教职生涯的研究员和年轻教员)翻译、多学科基础、临床或 基于人群的淋巴瘤研究。有时，CEP被用来帮助更有经验、更成功的人 有兴趣将研究重点转向转化性淋巴瘤研究的研究人员。孢子 CEP提供50,000美元，为期一年(25,000美元来自孢子基金，25,000美元来自 爱荷华大学或梅奥诊所资源)，每年颁发两个奖项。第二年的支持是 可能的基础是进步和成功的重新竞争。在最近一次供资期间(第11年- 15)，10名调查员，包括2名代表不足的少数族裔教员和4名妇女，获得了CEP奖 并分别支持1年。他们都是淋巴组织领域的活跃的翻译研究人员 10例恶性肿瘤中有9例仍与孢子有关，第10例是另一种成功的研究人员。 机构。前一个供资期间的CEP获奖者(Gupta)是当前项目3的共同领导者。 在此续签申请中，另一名CEP获奖者(Feldman)已成为项目1的联合负责人兼主任 生物群落的核心。杨博士的研究对提出的项目1和博士非常重要。 阿斯曼的研究使她在这次更新中扮演了生物谱系和生物信息学核心的角色。在.期间 在下一个资助期，孢子将维持：(1)严格的候选人遴选制度，鼓励 来自少数群体和妇女的申请；(2)由一名导师对受训人员进行全面指导；(3)通过 一个由调查人员组成的科学指导小组(个人见习指导委员会)， 每个受训人员感兴趣领域的专门知识；(4)多学科研究课程和持续培训 在两个地点举行的多学科癌症研讨会系列和淋巴瘤小组会议等活动； (5)鼓励与两个地点的调查员小组会议合作；(6)鼓励 与爱荷华州和梅奥州的调查人员合作，以及(7)进一步加强研究的机会 通过发展研究计划和完整的项目。

ABSTRACT: Career Enhancement Program (CEP). The goal of the University of Iowa/Mayo Clinic Lymphoma SPORE (SPORE) Career Enhancement Program (CEP) is to provide support (both financial support and extensive mentorship) to highly promising, well-trained scientists interested in pursuing a career in translational lymphoma research. The CEP allows for the support each year of two highly promising investigators who are engaged in SPORE research. The extensive research and training base available at these two institutions as well as the infrastructure of the SPORE provides an outstanding foundation for the SPORE CEP. Successful candidates for the SPORE CEP are typically young investigators (senior postdoctoral fellows about to begin their faculty careers, and young faculty) in translational, multidisciplinary basic, clinical or population-based lymphoma research. On occasion, the CEP is used to assist more experienced, successful investigators interested in shifting their research focus toward translational lymphoma research. The SPORE CEP provides $50,000 for one year ($25,000 from SPORE funds and institutional support of $25,000 from the University of Iowa or Mayo Clinic resources) for each of two awards per year. A second year of support is possible based on progress and successful re-competition. During this most recent funding period (years 11- 15), 10 investigators, including two under-represented minority faculty and four women, received CEP awards and were each supported for 1 year. They all remain active translational investigators in the field of lymphoid malignancies with 9 of the 10 still involved with the SPORE and the 10th a successful investigator at another institution. The CEP awardee (Gupta) from a previous funding period was a co-leader on the current Project 3. In this renewal application, another CEP awardee (Feldman) has become Project 1 co-leader and also Director of the Biospecimens Core. The research of Dr. Z. Yang was important to the proposed Project 1 and Dr. Asmann's research has led to her role in the Biospecimens and Bioinformatics Core in this renewal. During the next funding period, the SPORE will maintain: (1) a stringent candidate selection system that encourages applications from minorities and women; (2) comprehensive trainee guidance by a mentor; (3) support through a scientific mentor group (the Individual Trainee Mentorship Committee) comprised of investigators with expertise in each trainee's area of interest; (4) multi-disciplinary research courses and on-going training activities such as the Multidisciplinary Cancer Seminar Series and Lymphoma Group meetings at both sites; (5) encouragement of collaboration with investigator group meetings at both sites; (6) encouragement of collaboration with investigators at both Iowa and Mayo and (7) opportunities for further research enhancement through the Developmental Research Program and full Projects.